Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
País/Región como asunto
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Pediatr Pulmonol ; 58(2): 398-407, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36349504

RESUMEN

The cannabis plant is the most used federally illegal drug in the United States and is widely used by adolescents. Cannabis has complex effects on the body and mind. All health professionals who take care of adolescents with cystic fibrosis (CF) should be aware of the factors impacting cannabis use in CF. Given limited evidence regarding the benefits of cannabis and the significant risks, clinicians have the responsibility to identify risk of cannabis use early, counsel patients about the risks, provide a safe space for ongoing conversations about cannabis use in the context of CF care, and deliver evidence-based interventions.


Asunto(s)
Cannabis , Fibrosis Quística , Humanos , Adolescente , Estados Unidos/epidemiología , Fibrosis Quística/tratamiento farmacológico , Fibrosis Quística/psicología , Cannabis/efectos adversos , Salud Mental , Humo , Nicotiana
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA